Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance

Author： Pennisi Manuela Bertino Gaetano Gagliano Caterina Malaguarnera Michele Bella Rita Borzì Antonio Maria Madeddu Roberto Drago Filippo Malaguarnera Giulia

Publisher： MDPI

E-ISSN： 2072-6643|9|8|897-897

ISSN： 2072-6643

Source： Nutrients, Vol.9, Iss.8, 2017-08, pp. : 897-897

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Peginterferon α-2a (40kD) Plus Ribavirin in the Management of Chronic Hepatitis C Mono-Infection

By Simpson Dene Curran Monique P.

Disease Management & Health Outcomes, Vol. 14, Iss. 5, 2006-01 ,pp. : 303-320

Adis International

Access to resources Recommend Favorite

Validation of the FACT-BRM with interferon-α treated melanoma patients

By Paterson Amber Trask Peter Wagner Lynne Esper Peg Redman Bruce

Quality of Life Research, Vol. 14, Iss. 1, 2005-02 ,pp. : 133-139

Springer Publishing Company

Access to resources Recommend Favorite

Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection

By Cheng C.-H. Huang C.-C. Leu M.-L. Chiang C.-Y.F. Wu M.-S. Lai P.-C.

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1353-1357

Elsevier

Access to resources Recommend Favorite

Pegylated IFNs for chronic hepatitis C: an update

By Grace Michael J Cutler David L Bordens Ronald W

Expert Opinion on Drug Delivery, Vol. 2, Iss. 2, 2005-03 ,pp. : 219-226

Informa Healthcare

Access to resources Recommend Favorite

Intramuscular versus intradermal administration of anti-hepatitis B vaccine in non-cirrhotic hepatitis C patients

By Arbizu E.A. Marugan R.B. Grijalba J.Y. Serrano P.L. Grande L.G. Del Campo Terron S.

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2747-2750

Elsevier

Access to resources Recommend Favorite